1. Schepens CL, Brockhurst RJ. Uveal effusion. I. Clinical picture. Arch Ophthalmol. 1963. 70:189–201.
2. Brockhurst RJ. Nanophthalmos with uveal effusion: a new clinical entity. Arch Ophthalmol. 1975. 93:1989–1999.
3. Brockhurst RJ. Vortex vein decompression for nanophthalmic uveal effusion. Arch Ophthalmol. 1980. 98:1987–1990.
4. Gass JDM. Uveal effusion syndrome: a new hypothesis concerning pathogenesis and technique of surgical treatment. Trans Am Ophthalmol Soc. 1983. 81:246–260.
5. Trelstad RL, Silbermann NN, Brockhurst RJ. Nanophthalmic sclera: ultrastructural, histochemical, and biochemical observations. Arch Ophthalmol. 1982. 100:1935–1938.
6. Stewart DH III, Streeten BW, Brockhurst RJ, et al. Abnormal scleral collagen in nanophthalmos: an ultrastructural study. Arch Ophthalmol. 1991. 109:1017–1025.
7. Uyama M, Takahashi K, Kozaki J, et al. Uveal effusion syndrome: clinical features, surgical treatment, histologic examination of the sclera, and pathophysiology. Ophthalmology. 2000. 107:441–449.
8. Young RD. The ultrastructural organization of proteoglycans and collagen in human and rabbit scleral matrix. J Cell Sci. 1985. 74:95–104.
9. Oum BS. Uveal effusion. J Korean Ophthalmol Soc. 1986. 27:1013–1017.
10. Song SW, Kwak NH, Huh W. A case of nanophthalmos. J Korean Ophthalmol Soc. 1996. 37:687–692.